[go: up one dir, main page]

AR112440A1 - Forma cristalina de un inhibidor de bcl-2, un proceso para su preparación y composiciones farmacéuticas que la contienen - Google Patents

Forma cristalina de un inhibidor de bcl-2, un proceso para su preparación y composiciones farmacéuticas que la contienen

Info

Publication number
AR112440A1
AR112440A1 ARP180101871A AR112440A1 AR 112440 A1 AR112440 A1 AR 112440A1 AR P180101871 A ARP180101871 A AR P180101871A AR 112440 A1 AR112440 A1 AR 112440A1
Authority
AR
Argentina
Prior art keywords
bcl
inhibitor
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
Other languages
English (en)
Inventor
Blanc Alan Le
Sylvie Dhulut
Julie Linol
Michael Lynch
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Publication of AR112440A1 publication Critical patent/AR112440A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Forma cristalina II del hidrocloruro de N-(4-hidroxifenil)-3-{6-[((3S)-3-(4-morfolinilmetil)-3,4-dihidro-2(1H)-isoquinolinil)carbonil]-1,3-benzodioxol-5-il}-N-fenil-5,6,7,8-tetrahidro-1-indolizina carboxamida (Compuesto A. HCl) que muestra al menos las siguientes líneas de difracción (ángulo 2q de Bragg, expresado en grados ± 0,2º): 15,23 y 15,47. Reivindicación 2: Forma cristalina II del hidrocloruro de N-(4-hidroxifenil)-3-{6-[((3S)-3-(4-morfolinilmetil)-3,4-dihidro-2(1H)-isoquinolinil)carbonil]-1,3-benzodioxol-5-il}-N-fenil-5,6,7,8-tetrahidro-1-indolizina carboxamida (Compuesto A. HCl), caracterizada porque tiene un diagrama de difracción de rayos X de polvo que muestra al menos 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 o todas las siguientes líneas de difracción (ángulo 2q de Bragg, expresado en grados ± 0,2º): 4,09; 8,19; 9,15; 10,82; 12,83; 15,23; 15,47; 16,40; 19,17; 19,87; 20,39; 20,88; 21,76; 23,19; 24,06.
ARP180101871 2017-07-06 2018-07-05 Forma cristalina de un inhibidor de bcl-2, un proceso para su preparación y composiciones farmacéuticas que la contienen AR112440A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17305876 2017-07-06

Publications (1)

Publication Number Publication Date
AR112440A1 true AR112440A1 (es) 2019-10-30

Family

ID=59350835

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101871 AR112440A1 (es) 2017-07-06 2018-07-05 Forma cristalina de un inhibidor de bcl-2, un proceso para su preparación y composiciones farmacéuticas que la contienen

Country Status (3)

Country Link
AR (1) AR112440A1 (es)
TW (1) TWI672302B (es)
WO (1) WO2019008126A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3538010A4 (en) 2016-11-11 2020-07-22 Intuitive Surgical Operations Inc. REMOTE-CONTROLLED SURGICAL SYSTEM FOR MONITORING SURGICAL INSTRUMENT WEAR
WO2019134970A1 (en) * 2018-01-05 2019-07-11 Les Laboratoires Servier Novel salts of a bcl-2 inhibitor,related crystalline forms,method for preparing the same and pharmaceutical compositions containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2986002B1 (fr) * 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008979B1 (fr) * 2013-07-23 2015-07-24 Servier Lab Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
WO2019008126A1 (en) 2019-01-10
TWI672302B (zh) 2019-09-21
TW201906839A (zh) 2019-02-16

Similar Documents

Publication Publication Date Title
SA520411990B1 (ar) مركبات مفيدة لتثبيط إنزيم كيناز 7 المعتمد على السيكلين
WO2015200680A3 (en) Prmt5 inhibitors and uses thereof
PL3362445T3 (pl) Związki będące pochodnymi oksadiazoloamin jako inhibitor deacetylazy histonowej 6 oraz kompozycja farmaceutyczna obejmujące takie związki
SA520411524B1 (ar) مركبات تنشيط القسيم العضلي ثنائي الأميد واستخداماتها
EP4364795A3 (en) Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
MY183536A (en) Pharmaceutical compositions comprising azd9291
PH12016501813A1 (en) 1,3-benzodioxole derivative
TN2016000489A1 (en) Carboxamide derivatives.
PH12017501397A1 (en) (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
TN2016000491A1 (en) Carboxamide derivatives.
ZA202102783B (en) Novel salt of a bcl-2 inhibitor, related crystalline form, method for preparing the same and pharmaceutical compositions containing the same
AR112440A1 (es) Forma cristalina de un inhibidor de bcl-2, un proceso para su preparación y composiciones farmacéuticas que la contienen
WO2016142821A3 (en) Compositions containing a thrombin inhibitor
EP4342542A3 (en) Combination of regorafenib and nivolumab for treating cancer
MX2021010016A (es) Modificaciones cristalinas de clorhidrato de n-(4,5-bismetansulfon il-2-metilbenzoil)guanidina y sales de n-(4,5-bismetansulfonil-2-m etilbenzoil)guanidina.
SA519401845B1 (ar) مركبات ألكيل أمين حلقية غير متجانسة بنزوية واستخدامها
WO2016047967A3 (ko) N-(5-아릴아미도-2-메틸페닐)-5-메틸이소옥사졸-4-카복스아미드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 fms 키나아제 저해제

Legal Events

Date Code Title Description
FB Suspension of granting procedure